Feasibility and utility of using chromosomal aneusomy to further define the cytologic categories in nipple aspirate fluid specimens: A preliminary study

Cancer

Volumn 102, Issue 5, 2004, Pages 322-327

  Krishnamurthy, Savitri ^a   Zhao, Lian ^a   Hayes, Kimberly ^a   Glassman, Armand B ^a   Cristofanilli, Massimo ^a   Singletary, S Eva ^a   Hunt, Kelly K ^a   Kuerer, Henry M ^a   Sneige, Nour ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast carcinoma; Chromosomal aneusomy; Fluorescence in situ hybridization; Nipple aspirate fluid

Indexed keywords

ARTICLE; ASPIRATION BIOPSY; ASPIRATION CYTOLOGY; BREAST CARCINOMA; BREAST DISCHARGE; CANCER CLASSIFICATION; CHROMOSOME 1; CHROMOSOME 11; CHROMOSOME 17; CHROMOSOME 8; CHROMOSOME ANALYSIS; DISOMY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

BIOPSY, NEEDLE; BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 8; EPITHELIAL CELLS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MAMMARY GLANDS, HUMAN; NIPPLES; RETROSPECTIVE STUDIES;

EID: 5644273990     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20558     Document Type: Article

References (23)

1. Dooley WC, Ljung BM, Veronesi U, et al. Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst. 2001;93:1624-1632.
2. Wrensch MR, Petrakis NL, Miike R, et al. Breast cancer risk in women with abnormal cytology in nipple aspirates breast fluid. J Natl Cancer Inst. 2001;93:1791-1798.
3. NIH Consensus Development Conference. The uniform approach to breast fine-needle aspiration biopsy. Am J Surg. 1997;174:371-385.
4. Bieche I, Champene MH, Matifas F, et al. Two distinct regions involved in 1p deletion in human primary breast cancer. Cancer Res. 1993;53:1990-1994.
5. Winqvist R, Mannermaa A, Alavaikko M, et al. Refinement of regional loss of heterozygosity for chromosome 11p15.5 in human breast tumors. Cancer Res. 1993;53:4486-4488.
6. Andersen TI, Gaustad A, Ottestad L, et al. Genetic alterations of the tumor suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas. Genes Chromosomes Cancer. 1992;4:113-121.
7. Pandis N, Heim S, Bardi G, et al. Whole-arm t(1;16) and i(1q) as sole anomalies identify gain of 1q as a primary chromosomal abnormality in breast cancer. Genes Chromosomes Cancer. 1992;5:235-238.
8. Mendelin J, Grayson M, Wallis T, et al. Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization. Lab Invest. 1999;79:387-393.
9. Mark HF, Taylor W, Brown S, et al. Abnormal chromosome 8 copy number in stage I to stage IV breast cancer studied by fluorescence in situ hybridization. Cancer Genet Cytogenet. 1999;108:1-5.
10. Roka S, Fiegl M, Zojer N, et al. Aneuploidy of chromosome 8 as detected by interphase fluorescence in situ hybridization is a recurrent finding in primary and metastatic breast cancer. Breast Cancer Res Treat. 1998;48:125-133.
11. Marinho AF, Botelho M, Schmitt FC. Evaluation of numerical abnormalities of chromosomes 1 and 17 in proliferative epithelial breast lesions using fluorescence in situ hybridization. Pathol Res Pract. 2000;196:227-233.
12. Cummings MC, Aubele M, Mattis A, et al. Increasing chromosome 1 copy number parallels histological progression in breast carcinogenesis. Br J Cancer. 2000;82:1204-1210.
13. Visscher D, Jimenez RE, Grayson M III, et al. Histopathologic analysis of chromosome aneuploidy in ductal carcinoma in situ. Hum Pathol. 2000;31:201-207.
14. Botti C, Pescatore B, Mottolese M, et al. Incidence of chromosomes 1 and 17 aneusomy in breast cancer and adjacent tissue: an interphase cytogenetic study. J Am Coll Surg. 2000;190:530-539.
15. Harrison M, Magee HM, O'Loughlin J, et al. Chromosome 1 aneusomy, identified by interphase cytogenetics, in mammographically detected ductal carcinoma in situ of the breast. J Pathol. 1995;175:303-309.
16. Micale MA, Vissher DW, Gulino SE, et al. Chromosomal aneuploidy in proliferative breast disease. Hum Pathol. 1994;25:29-35.
17. Matsumura K, Kallioniemi A, Kallioniemi O, et al. Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization. Cancer Res. 1992;52:3474-3477.
18. Tsukamoto F, Miyoshi Y, Koyama H, et al. Detection of chromosomal aneusomy by fluorescence in situ hybridization in fine-needle aspirates from breast tumors: application to the preoperative diagnosis of breast carcinoma. Cancer. 2000;90:373-378.
19. McManus DT, Patterson AH, Maxwell P, et al. Interphase cytogenetics of chromosomes 11 and 17 in fine needle aspirates of breast cancer. Hum Pathol. 1999;30:137-144.
20. Cajulis RS, Frias-Hidvegi D. Detection of numerical chromosomal abnormalities in malignant cells in fine needle aspirates by fluorescence in situ hybridization of interphase cell nuclei with chromosome-specific probes. Acta Cytol. 1993;37:391-396.
21. Yamamoto D, Senzaki H, Nakagawa H, et al. Detection of chromosomal aneusomy by fluorescence in situ hybridization for patients with nipple discharge. Cancer. 2003;97:690-694.
22. King BL, Tsai SC, Gryga ME, et al. Detection of chromosomal instability in paired breast surgery and ductal lavage specimens by interphase fluorescence in situ hybridization. Clin Cancer Res. 2003;9:1509-1516.
23. Krishnamurthy S, Sneige N, Thompson PA, et al. Nipple aspirate fluid cytology in breast carcinoma. Cancer. 2003;99:97-104.